A detailed history of Fine Mark National Bank & Trust transactions in Eli Lilly & CO stock. As of the latest transaction made, Fine Mark National Bank & Trust holds 17,921 shares of LLY stock, worth $13.4 Million. This represents 0.56% of its overall portfolio holdings.

Number of Shares
17,921
Previous 18,650 3.91%
Holding current value
$13.4 Million
Previous $16.9 Million 5.98%
% of portfolio
0.56%
Previous 0.62%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$772.14 - $960.02 $562,890 - $699,854
-729 Reduced 3.91%
17,921 $15.9 Million
Q2 2024

Aug 02, 2024

SELL
$724.87 - $909.04 $388,530 - $487,245
-536 Reduced 2.79%
18,650 $16.9 Million
Q1 2024

May 14, 2024

SELL
$592.2 - $792.28 $299,061 - $400,101
-505 Reduced 2.56%
19,186 $14.9 Million
Q4 2023

Feb 09, 2024

SELL
$525.19 - $619.13 $19,957 - $23,526
-38 Reduced 0.19%
19,691 $11.5 Million
Q3 2023

Nov 15, 2023

BUY
$434.7 - $599.3 $101,719 - $140,236
234 Added 1.2%
19,729 $10.6 Million
Q2 2023

Aug 11, 2023

BUY
$350.74 - $468.98 $212,899 - $284,670
607 Added 3.21%
19,495 $9.14 Million
Q1 2023

May 08, 2023

SELL
$310.63 - $364.82 $451,345 - $530,083
-1,453 Reduced 7.14%
18,888 $6.49 Million
Q4 2022

Feb 09, 2023

SELL
$321.55 - $374.67 $231,194 - $269,387
-719 Reduced 3.41%
20,341 $7.44 Million
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $304,484 - $346,992
-1,027 Reduced 4.65%
21,060 $6.81 Million
Q2 2022

Aug 09, 2022

SELL
$278.73 - $327.27 $125,985 - $147,926
-452 Reduced 2.01%
22,087 $7.16 Million
Q1 2022

May 16, 2022

BUY
$234.69 - $291.66 $13,846 - $17,207
59 Added 0.26%
22,539 $6.45 Million
Q4 2021

Feb 14, 2022

SELL
$224.85 - $279.04 $288,482 - $358,008
-1,283 Reduced 5.4%
22,480 $6.21 Million
Q3 2021

Nov 12, 2021

BUY
$221.6 - $272.71 $204,093 - $251,165
921 Added 4.03%
23,763 $5.49 Million
Q2 2021

Aug 13, 2021

SELL
$180.55 - $233.54 $152,925 - $197,808
-847 Reduced 3.58%
22,842 $5.24 Million
Q1 2021

May 12, 2021

SELL
$164.32 - $212.72 $51,432 - $66,581
-313 Reduced 1.3%
23,689 $4.43 Million
Q4 2020

Feb 10, 2021

BUY
$130.46 - $172.63 $1,043 - $1,381
8 Added 0.03%
24,002 $4.05 Million
Q3 2020

Nov 12, 2020

SELL
$146.22 - $169.13 $18,569 - $21,479
-127 Reduced 0.53%
23,994 $3.55 Million
Q2 2020

Aug 13, 2020

SELL
$136.42 - $164.18 $94,675 - $113,940
-694 Reduced 2.8%
24,121 $3.96 Million
Q1 2020

May 06, 2020

SELL
$119.05 - $147.35 $61,667 - $76,327
-518 Reduced 2.04%
24,815 $3.44 Million
Q4 2019

Feb 07, 2020

SELL
$106.92 - $132.43 $21,918 - $27,148
-205 Reduced 0.8%
25,333 $3.33 Million
Q3 2019

Nov 08, 2019

BUY
$106.79 - $116.16 $54,249 - $59,009
508 Added 2.03%
25,538 $2.86 Million
Q2 2019

Aug 08, 2019

SELL
$110.79 - $129.32 $65,366 - $76,298
-590 Reduced 2.3%
25,030 $2.77 Million
Q1 2019

May 07, 2019

SELL
$111.31 - $131.02 $292,188 - $343,927
-2,625 Reduced 9.29%
25,620 $3.32 Million
Q4 2018

Feb 07, 2019

SELL
$105.9 - $118.64 $103,252 - $115,674
-975 Reduced 3.34%
28,245 $3.27 Million
Q3 2018

Nov 02, 2018

SELL
$85.86 - $107.31 $163,305 - $204,103
-1,902 Reduced 6.11%
29,220 $3.14 Million
Q2 2018

Aug 03, 2018

BUY
$75.7 - $86.88 $69,189 - $79,408
914 Added 3.03%
31,122 $2.66 Million
Q1 2018

Apr 26, 2018

BUY
$74.21 - $87.6 $143,522 - $169,418
1,934 Added 6.84%
30,208 $2.34 Million
Q4 2017

Jan 30, 2018

SELL
$81.94 - $87.89 $21,058 - $22,587
-257 Reduced 0.9%
28,274 $2.39 Million
Q3 2017

Oct 30, 2017

BUY
$77.07 - $85.54 $2.2 Million - $2.44 Million
28,531
28,531 $2.44 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Fine Mark National Bank & Trust Portfolio

Follow Fine Mark National Bank & Trust and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fine Mark National Bank & Trust, based on Form 13F filings with the SEC.

News

Stay updated on Fine Mark National Bank & Trust with notifications on news.